klaguia

发表

The Transfer of Technologies Towards a Personalized Approach

klaguia, 2008 .

Building an International Code of Conduct for Genomic Cloud Research

klaguia, 2017 .

A decision tool to guide the ethics review of a challenging breed of emerging genomic projects

klaguia, 2016 .

Balancing Privacy Protections with Open, Collaborative, Biomedical Research: Implications for Updating the CIHR Privacy Best Practices Document

klaguia, 2011 .

Stored tissue samples: Through the confidentiality maze

klaguia, 2005 .

Prepublication Data Sharing

klaguia, 2009 .

General Problems Related to the Collection and Processing of Health Related Information for Insurance Purposes Including those which are Specific to Predictive Health Data

klaguia, 2010 .

Harnessing Omics Sciences, Population Databases, and Open Innovation for Theranostics-Guided Drug Discovery and Development

klaguia, 2012 .

Personalized Medicine: Not a sprint, but a relay

klaguia, 2011 .

Beyond ELSIs – Where to From Here? From ‘Regulators’ to Anticipating and Shaping the Innovation Trajectory in Personalized Medicine

klaguia, 2013 .

Of Clouds and Genomic Data Protection

klaguia, 2017 .

Genomic cloud computing: legal and ethical points to consider

klaguia, 2014 .

Epigenome data release: a participant-centered approach to privacy protection

klaguia, 2016 .

Opportunities and Challenges Provided by Cloud Repositories for Bioinformatics-Enabled Drug Discovery

klaguia, 2014 .

Bilski v. Kappos and biotechnology patents: Back to the future?

klaguia, 2012 .

Genetic Research Tools, the Research Exception and Open Science

klaguia, 2005 .

Five Years of Controlled Access at ICGC: Building a Key to the Data Sharing Highway

klaguia, 2016 .

The regulation of novel water quality assessment biotechnologies: Is Canada ready to ride the next wave?

klaguia, 2016 .

International genomic cloud computing – ‘Mining’ the Terms of Service

klaguia, 2015 .

International Network of Cancer Genome Projects

klaguia, 2010 .

The Emergence of an Ethical Duty to Disclose Genetic Research Results

klaguia, 2006 .

Making an Impact: A Preferred Framework and Indicators to Measure Returns on Investment in Health Research

klaguia, 2009 .

Open Science and Community Norms: Data Retention and Publication Moratoria Policies in Genomics Projects

klaguia, 2012 .

Reflections on the Cost of ‘Low-Cost’ Whole Genome Sequencing: Framing the Health Policy Debate

klaguia, Mildred Cho, 2013 .

Genomic Databases Access Agreements: Legal Validity and Possible Sanctions

klaguia, 2011 .

Legal Aspects of Genetic Databases for International Biomedical Research: The Example of the International Cancer Genome Consortium (ICGC)

klaguia, 2012 .

Data Sharing in the Post-Genomic World: the Experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO)

klaguia, 2012 .

Open Biotechnology: Licenses Needed

klaguia, 2010 .

Trade-Secret Model: Legal Limitations

klaguia, 2011 .

Pharmacogenomics: Don’t Forget the Children

klaguia, 2008 .

Power to the People: A Wiki Governance Model for Biobanks

klaguia, 2012 .

Commercial opportunities and ethical pitfalls in personalized medicine: a myriad of reasons to revisit the Myriad Genetics saga

klaguia, 2013 .

Personalized Vaccines and Public Health Genomics: Anticipating and Monitoring the ELSIs

klaguia, 2010 .

Genetic Information and Insurance Underwriting: Contemporary Issues and Approaches in the Global Economy Insurance

klaguia, 2008 .

Genetics and Life Insurance: A Comparative Analysis

klaguia, 2004 .

Incidental Findings in Data-Intensive Postgenomics Science and Legal Liability of Clinician-Researchers: Ready for Vaccinomics?

klaguia, 2011 .

Evaluation of BRCA1 and BRCA2 Mutation Prevalence, Risk Prediction Models and a Multi-Step Testing Approach in French-Canadian High-Risk Breast and/or Ovarian Cancer Families

klaguia, 2007 .

An Implementation Framework for the Feedback of Individual Research Results and Incidental Findings in Research

klaguia, 2016 .

Human Gene Patents and Genetic Testing

klaguia, 2010 .

Points to Consider: The Commercialization of Genomic Research in Canada

klaguia, 2010 .

Controlled Access under Review: Improving the Governance of Genomic Data Access

klaguia, 2016 .

Making an Impact: A Preferred Framework and Indicators to Measure Returns on Investment in Health Research

klaguia, 2009 .

Moving Beyond Commercialization: Strategies to Maximize the Economic and Social Impact of Genomic Research

klaguia, 2012 .